Yes, there are effective treatments for alopecia, and the options have expanded significantly in recent years. The right treatment depends on which type of hair loss you have. Pattern baldness (androgenetic alopecia), autoimmune hair loss (alopecia areata), and scarring alopecia each respond to different approaches, ranging from daily medications to newer targeted therapies approved since 2022.
Pattern Hair Loss: The Most Common Type
Androgenetic alopecia, the gradual thinning that affects both men and women, has the longest track record of effective treatments. Two medications form the foundation: one blocks the hormone that causes hair follicles to shrink, and the other increases blood flow to the scalp to stimulate growth.
The hormone-blocking option (finasteride) works by stopping testosterone from converting into DHT, the hormone directly responsible for follicle miniaturization in pattern baldness. For men, it’s widely considered more effective than the blood-flow approach. A related medication, dutasteride, blocks DHT even more aggressively and sits at the top of the effectiveness hierarchy in comparative research.
Minoxidil, the blood-flow stimulant, is available over the counter as a topical liquid or foam and also prescribed in low oral doses. It works for both men and women. You’ll typically see fine, thin hairs appear at 8 to 12 weeks, with thicker, pigmented regrowth by 4 to 6 months. Combining both medications in a single topical solution has been shown to improve hair count and reduce the balding area beyond what either achieves alone.
For women specifically, a combination of low-dose oral minoxidil (typically around 1 to 2 mg) with an anti-androgen medication is a common approach. Starting both at the same time reduced the risk of unwanted facial or body hair growth by about 65% compared to starting them separately, based on a retrospective study of female patients.
Finasteride Side Effects Worth Knowing
Finasteride carries a real, if modest, risk of sexual side effects. A meta-analysis of men taking it for pattern hair loss found the relative risk of sexual side effects was 1.6 times higher than placebo. One observational study flagged that younger men taking it for more than about seven months had a nearly fivefold higher risk of persistent erectile issues compared to shorter courses.
There’s also a link to mood changes. A systematic review found that people taking finasteride had a 1.31 times higher average risk of clinical depression. In adverse event reports, about half of sexual dysfunction cases and 39% of depressive disorder cases were recorded as unresolved at the time of reporting. These numbers don’t mean most people will experience problems, but they’re worth weighing, especially for younger men considering long-term use.
Alopecia Areata: New FDA-Approved Options
Alopecia areata is an autoimmune condition where the immune system attacks hair follicles, causing patchy or total hair loss. Treatment looked very different before 2022, relying mainly on corticosteroid injections and topical immune therapies. Since then, three targeted oral medications called JAK inhibitors have received FDA approval for severe cases.
These three options are baricitinib (approved for adults 18 and older), ritlecitinib (approved for ages 12 and up, making it the only one available for adolescents), and deuruxolitinib (approved for adults). They work by calming the specific immune signaling pathways that drive the attack on hair follicles.
Clinical trial data for baricitinib gives a sense of what to expect. Among patients who responded to the higher dose and achieved at least 80% scalp coverage, 75% went on to reach near-complete coverage by week 52. About 63% achieved essentially full regrowth. Results build gradually: visible improvement typically begins within 12 to 24 weeks, with continued gains up to 9 to 12 months.
Older Treatments Still in Use
For milder or patchy alopecia areata, dermatologists still use corticosteroids, either applied topically or injected directly into bald patches. Injections tend to produce initial hair budding within 6 to 8 weeks, with more noticeable regrowth over 3 to 6 months. Topical contact immunotherapy, which deliberately triggers a mild allergic reaction on the scalp to redirect the immune system, can produce regrowth starting at 3 to 6 months, with the best results by 9 to 12 months. Response to this approach is often unpredictable.
Scarring Alopecia: Stopping Progression
Scarring (cicatricial) alopecia permanently destroys hair follicles through inflammation, so the treatment goals are different. The priority is stopping further loss and relieving symptoms like itching or tenderness. Regrowing hair is sometimes possible in areas where follicles haven’t been fully destroyed, but it’s not guaranteed.
Treatment typically combines multiple medications. A common plan includes prescription-strength corticosteroids applied at home, periodic corticosteroid injections at a dermatologist’s office, and daily application of minoxidil. Minoxidil alone is not enough for scarring alopecia and must be used alongside anti-inflammatory treatments. If there’s scaling on the scalp, a dandruff shampoo can help manage that symptom.
Laser Therapy and PRP
Low-level laser therapy (LLLT), delivered through laser caps or combs, uses red light at wavelengths around 633 nm to stimulate follicle activity. In a randomized controlled trial comparing LLLT to topical minoxidil in men with pattern hair loss, the laser group saw mean hair density increase from about 105 hairs per square centimeter at baseline to 130 at six months. Sessions were 10 minutes each, three times per week. It’s a slower, more modest improvement than medications, but it has virtually no systemic side effects.
Platelet-rich plasma (PRP) therapy involves drawing your blood, concentrating the growth-factor-rich portion, and injecting it into the scalp. Studies have shown improvements in hair density and patient satisfaction for pattern hair loss. It’s typically done as a series of sessions spaced a month apart, then maintained with periodic treatments. It’s not covered by most insurance plans.
Hair Transplant Surgery
When medications and other treatments aren’t enough, surgical hair transplantation moves follicles from thicker areas (usually the back of the head) to thinning areas. Two main techniques exist: follicular unit transplantation (FUT), which removes a thin strip of scalp, and follicular unit extraction (FUE), which harvests individual follicle clusters.
In a comparative study of nearly 1,800 follicles across four patients, FUT grafts had an 86% survival rate while FUE grafts survived at about 61%. Excluding one outlier patient who had unusually poor FUE results, FUE survival rose to roughly 70%. Three-hair grafts tended to survive better than single-hair grafts with both methods. FUE leaves no linear scar and has a shorter recovery, which makes it more popular despite the somewhat lower graft survival numbers. Most candidates are people with stable pattern hair loss and enough donor hair in the back and sides of the scalp.
How Long Before You See Results
Patience is the hardest part of hair loss treatment. Nearly every option requires months before visible change appears. Topical corticosteroids may produce fine hairs within 6 to 12 weeks, but meaningful regrowth takes 3 to 6 months. Minoxidil follows a similar timeline. JAK inhibitors for alopecia areata generally show improvement at 12 to 24 weeks, with results continuing to build for up to a year. Contact immunotherapy can take 9 to 12 months to reach its full effect.
Most treatments also require ongoing use. Stopping minoxidil or finasteride typically leads to renewed hair loss within several months. JAK inhibitors for alopecia areata work by suppressing the immune attack, not by curing it, so hair loss can return if the medication is discontinued. Hair transplants are the exception: transplanted follicles are permanent, though you may still lose non-transplanted hair over time without medical maintenance.